MAIA Biotechnology annual current ratio
2021
2022
2023
2024
2025
MAIA Biotechnology Current Ratio Growth & History (MAIA)
MAIA Biotechnology's current ratio was 1.66 for fiscal 2025.
View full MAIA Biotechnology company overviewMAIA Biotechnology annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.66 | −0.99 | −37.29% |
| 2024 | 2024-12-31 | 2.65 | 1.12 | +73.02% |
| 2023 | 2023-12-31 | 1.53 | −2.08 | −57.59% |
| 2022 | 2022-12-31 | 3.61 | −1.36 | −27.37% |
| 2021 | 2021-12-31 | 4.97 | — | — |
MAIA Biotechnology quarterly current ratio
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.51 | 2.32 | +106.10% |
| Q1 2026 | 2026-03-31 | 5.59 | 3.24 | +138.16% |
| Q4 2025 | 2025-12-31 | 1.66 | −0.99 | −37.29% |
| Q3 2025 | 2025-09-30 | 1.18 | −1.38 | −54.06% |
| Q2 2025 | 2025-06-30 | 2.19 | −1.23 | −36.03% |
| Q1 2025 | 2025-03-31 | 2.35 | 0.57 | +32.31% |
| Q4 2024 | 2024-12-31 | 2.65 | 1.12 | +73.02% |
| Q3 2024 | 2024-09-30 | 2.56 | 0.96 | +60.19% |
| Q2 2024 | 2024-06-30 | 3.42 | 0.44 | +14.58% |
| Q1 2024 | 2024-03-31 | 1.77 | −0.44 | −19.88% |
| Q4 2023 | 2023-12-31 | 1.53 | −2.08 | −57.59% |
| Q3 2023 | 2023-09-30 | 1.60 | −4.42 | −73.44% |
| Q2 2023 | 2023-06-30 | 2.99 | 0.21 | +7.47% |
| Q1 2023 | 2023-03-31 | 2.21 | — | — |
| Q4 2022 | 2022-12-31 | 3.61 | −1.36 | −27.37% |
| Q3 2022 | 2022-09-30 | 6.02 | — | — |
| Q2 2022 | 2022-06-30 | 2.78 | — | — |
| Q4 2021 | 2021-12-31 | 4.97 | — | — |
MAIA Biotechnology current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, MAIA Biotechnology's current ratio decreased from 4.97 to 1.66, a change of −3.31. The latest reported quarter, Q2 2026, shows 4.51.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MAIA Biotechnology source filings ↗